An immunosuppressive tumor microenvironment has hampered the efficacy of
immunotherapy in prostate cancer. However, radiation-induced immunological effects can …

Purpose To obtain individualized internal doses with a Monte Carlo (MC) method in patients
undergoing diagnostic [18F] FCH‐PET studies and to compare such doses with the MIRD …

Purpose Approximately 50% of head and neck cancer (HNC) patients will experience loco‐
regional disease recurrence following initial courses of therapy. Retreatment with external …

Introduction: CLR1404 is a theranostic molecular agent that can be radiolabeled with 124I
(CLR 124) for positron emission tomography (PET) imaging, or 131I (CLR 131) for single …

Purpose Targeted radiopharmaceutical therapy (RPT) in combination with external beam
radiation therapy (EBRT) shows promise as a method to increase tumor control and mitigate …

Radionuclide therapy (RNT) uses systemically administered radiopharmaceuticals directed
to a specific cancer-associated target to provide low-dose rate (LDR) treatment. The …

In this chapter, the framework for the application of the Monte Carlo method to a wide range
of problems in nuclear medicine dosimetry is introduced. It also presents an introductory …

Voxel-level dosimetry based on nuclear medicine images offers patient-specific
personalization of radiopharmaceutical therapy (RPT) treatments. Clinical evidence is …

In internal dosimetry, the Monte Carlo technique is used for radiation transport to compute
values of efficiency of monitoring systems and energy deposition in various organs followed …

To estimate the absorbed dose of patients undergoing diagnostic PET with [18F] FDG by
using the MIRD and MC methods, a female patient phantom was considered. The organ …